相关实验视频
Updated: Jun 3, 2025

08:10
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
80.5K
儿童结核病中的GeneXpert MTB/RIF Ultra:疾病特征如何改变测试表现
Domenico Pace1,2, Roberta Pellegrino1,2, Irene Dalpiaz1,2
1Department of Health Sciences, University of Florence, Florence, Italy.
Current pediatric reviews
|January 8, 2025
概括
诊断儿科结核病 (TB) 是一个挑战,但GeneXpert和GeneXpert Ultra提供了更高的准确性. GeneXpert Ultra显示了更高的检测率,特别是儿童肺外结核病.
科学领域:
- 儿童传染病 儿童传染病
- 微生物学 微生物学
- 分子诊断学 分子诊断学
背景情况:
- 儿童结核病 (TB) 诊断受到传统微生物学测试 (如培养和显微镜) 的低灵敏度的阻碍.
- 分子测试,GeneXpert MTB/RIF和GeneXpert MTB/RIF Ultra,提供快速检测的结核菌和耐药性突变.
- 这些实时聚合酶连锁反应试验旨在提高儿童的诊断准确性.
研究的目的:
- 评估GeneXpert MTB/RIF和GeneXpert MTB/RIF Ultra在儿童结核病病例中的诊断准确度.
- 为了比较GeneXpert和GeneXpert Ultra在儿童肺结核和肺外结核诊断中的性能.
- 评估患者特征对测试性能的影响.
主要方法:
- 一项回顾性单中心研究,涉及95名可能或确诊结核病的儿童.
- 从2013年到2023年,儿童使用GeneXpert MTB/RIF或GeneXpert MTB/RIF Ultra进行了测试.
- 分析包括诊断检测率和测试类型和结核病位置之间的比较.
主要成果:
- 基因Xpert MTB/RIF和基因Xpert Ultra的检测率分别为35.7%和53.7%.
- 与肺结核相比,GeneXpert Ultra显示出肺外结核的检测率显著更高 (81.3%).
- 胃吸入液是最有效的样本类型;非侵入性样本产生了差的结果. 有可能进行快速基因型药物敏感性测试,以检测瑞芬辛耐药性.
结论:
- 通过提供快速的微生物信息,GeneXpert和GeneXpert Ultra显著提高了儿科结核病诊断.
- 这些分子测试补充了传统的培养方法,这些方法仍然是儿科结核病的黄金标准.
- 改进的诊断能力有助于及时准确地治疗儿童结核病.
相关概念视频
Pulmonary Tuberculosis IV
133
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
133
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis III
303
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
303
Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Pulmonary Tuberculosis II
211
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
211

